TY - JOUR
T1 - Parasomnias
T2 - Common and rare types, diagnosis, prevention, and management of nrem parasomnias
AU - Khan, Safia S.
AU - Khawaja, Imran S.
N1 - Funding Information:
ABSTRACT nosed by clinical history. Nonpharma-Parasomnias are described as unde-cologic interventions that are effective sirable motor activity displayed during for NREM parasomnias include relax-sleep. Parasomnias are generally char-ation, hypnosis, anticipatory awaken-acterized by abrupt talking, scream-ings, and ensuring environmental ing, walking, confusional arousals, safety to reduce the risk of injury to bruxism (ie, teeth grinding), or other the patient, bed partners, and family complex activity arising from nonmembers. Pharmaceuticals shown to rapid eye movement (NREM) stages, have significant effectiveness in NREM rapid eye movement (REM) stages, or parasomnias include melatonin, benzo-transitions between sleep stages and diazepines, tricyclic antidepressants, sleep-wake states. Parasomnias are as-and medications that reduce arousals. sociated with a poor recall of events by [Psychiatr Ann. 2021;51(12):550-555.] the patient, making information from a bed partner valuable. The use of at- tended polysomnography (PSG) with arasomnias are defined as “un- continuous audio and video recording desirable physical events or and the inclusion of extended electro-P experiences that occur during encephalographic (EEG) montage is re-entry into sleep, within sleep, or during quired to diagnose REM parasomnias. arousals from sleep” in the International PSG is not required for the diagnosis of Classification of Sleep Disorders, third NREM parasomnias, as these are diag-edition.1 Among younger patients, pa- From Parkland Medical Hospital, Dallas, Texas (SSK); University of Texas South-western Medical Center, Dallas, Texas (SSK); Texas Health Presbyterian Hospital, Dallas, Texas (SSK); Department of Psychiatry, University of Oklahoma, Oklahoma City, Oklahoma (ISK); and MD TruCare PA, Grapevine and Fort Worth, Texas Texas (ISK). Address correspondence to Safia S. Khan, MD, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390; email: Safia.khan@ utsouthwestern.edu. Grant: Safia S. Khan receives a research grant (5R01HL142605) as Co-Investigator from NIH-National Heart, Lung and Blood Institute to study the relationship of obesity and sleep apnea in pregnancy. Disclosure: The authors have no relevant financial relationships to disclose. doi:10.3928/00485713-20211110-01
Publisher Copyright:
© SLACK Incorporated.
PY - 2021/12
Y1 - 2021/12
N2 - Parasomnias are described as undesirable motor activity displayed during sleep. Parasomnias are generally characterized by abrupt talking, screaming, walking, confusional arousals, bruxism (ie, teeth grinding), or other complex activity arising from nonrapid eye movement (NREM) stages, rapid eye movement (REM) stages, or transitions between sleep stages and sleep-wake states. Parasomnias are associated with a poor recall of events by the patient, making information from a bed partner valuable. The use of attended polysomnography (PSG) with continuous audio and video recording and the inclusion of extended electroencephalographic (EEG) montage is required to diagnose REM parasomnias. PSG is not required for the diagnosis of NREM parasomnias, as these are diag nosed by clinical history. Nonpharmacologic interventions that are effective for NREM parasomnias include relaxation, hypnosis, anticipatory awakenings, and ensuring environmental safety to reduce the risk of injury to the patient, bed partners, and family members. Pharmaceuticals shown to have significant effectiveness in NREM parasomnias include melatonin, benzodiazepines, tricyclic antidepressants, and medications that reduce arousals.
AB - Parasomnias are described as undesirable motor activity displayed during sleep. Parasomnias are generally characterized by abrupt talking, screaming, walking, confusional arousals, bruxism (ie, teeth grinding), or other complex activity arising from nonrapid eye movement (NREM) stages, rapid eye movement (REM) stages, or transitions between sleep stages and sleep-wake states. Parasomnias are associated with a poor recall of events by the patient, making information from a bed partner valuable. The use of attended polysomnography (PSG) with continuous audio and video recording and the inclusion of extended electroencephalographic (EEG) montage is required to diagnose REM parasomnias. PSG is not required for the diagnosis of NREM parasomnias, as these are diag nosed by clinical history. Nonpharmacologic interventions that are effective for NREM parasomnias include relaxation, hypnosis, anticipatory awakenings, and ensuring environmental safety to reduce the risk of injury to the patient, bed partners, and family members. Pharmaceuticals shown to have significant effectiveness in NREM parasomnias include melatonin, benzodiazepines, tricyclic antidepressants, and medications that reduce arousals.
UR - http://www.scopus.com/inward/record.url?scp=85121328089&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85121328089&partnerID=8YFLogxK
U2 - 10.3928/00485713-20211110-01
DO - 10.3928/00485713-20211110-01
M3 - Article
AN - SCOPUS:85121328089
SN - 0048-5713
VL - 51
SP - 550
EP - 555
JO - Psychiatric Annals
JF - Psychiatric Annals
IS - 12
ER -